© 1993 by Oxford University Press
Journal of the National Cancer Institute, Vol. 85, No. 12, 958-964,
June 16, 1993
© 1993 Oxford University Press
Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia
Epidemiology and Biostatistics Program, Division of Cancer Etiology, National Cancer Institute Bethesda, Md
Cetus Corporation Emeryville, Calif
Kaiser Permanente, Portland, Ore
Westat, Inc. Rockville, Md
Department of Pathology. The Johns Hopkins Medical Institutions Baltimore, Md
Correspondence to: Mark H. Schiffman, M.D., M.P.H., National Institutes of Health, Executive Plaza North, Rm. 443, Bethesda, MD 20892.
BACKGROUND:: Experimental studies have provided strong evidence that human papillomavirus (HPV) is the long-sought venereal cause of cervical neoplasia, but the epidemiologic evidence has been inconsistent. Purpose: Given improvements in HPV testing that have revealed a strong link between sexual activity history and cervical HPV infection, we conducted a large case-control study of HPV and cervical intraepithelial neoplasia (CIN) to evaluate whether sexual behavior and the other established risk factors for CIN influence risk primarily via HPV infection. Methods: We studied 500 women with CIN and 500 control subjects receiving cytologic screening at Kaiser Permanente, a large prepaid health plan, in Portland, Ore. The established epidemiologic risk factors for CIN were assessed by telephone interview. We performed HPV testing of cervicovaginal lavage specimens by gene amplification using polymerase chain reaction with a consensus primer to target the LI gene region of HPV. Unconditional logistic regression analysis was used to estimate relative risk of CIN and to adjust the epidemiologic associations for HPV test results to demonstrate whether the associations were mediated by HPV. Results: The case subjects demonstrated the typical epidemiologic profile of CIN: They had more sex partners, more cigarette smoking, earlier ages at first sexual intercourse, and lower socioeconomic status. Statistical adjustment for HPV infection substantially reduced the size of each of these case-control differences. Seventy-six percent of cases could be attributed to HPV infection; the results of cytologic review suggested that the true percentage was even higher. Once HPV infection was taken into account, an association of parity with risk of CIN was observed in both HPV-negative and HPV-positive women. Conclusion: The data show that the great majority of all grades of CIN can be attributed to HPV infection, particularly with the cancer-associated types of HPV. Implications: In light of this conclusion, the investigation of the natural history of HPV has preventive as well as etiologic importance. [J Natl Cancer Inst 85:958–964, 1993]
CiteULike 
Connotea 
Del.icio.us What's this?
Online Perspective about this Classic Article
- Epidemiologic Studies of a Necessary Causal Risk Factor: Human Papillomavirus Infection and Cervical Neoplasia
- Mark H. Schiffman and Philip Castle
J Natl Cancer Inst 2003 95: 2E.[Extract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  E L Franco and A R Spence Commentary: Smoking and human papillomavirus infection: the pursuit of credibility for an epidemiologic association Int. J. Epidemiol., June 1, 2008; 37(3): 547 - 548. [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Giuliano and D. Salmon The Case for a Gender-Neutral (Universal) Human Papillomavirus Vaccination Policy in the United States: Point Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 805 - 808. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schmitt, B. Dondog, T. Waterboer, and M. Pawlita Homogeneous Amplification of Genital Human Alpha Papillomaviruses by PCR Using Novel Broad-Spectrum GP5+ and GP6+ Primers J. Clin. Microbiol., March 1, 2008; 46(3): 1050 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Cooper, N. Brimer, and S. B. Vande Pol Human Papillomavirus E6 Regulates the Cytoskeleton Dynamics of Keratinocytes through Targeted Degradation of p53 J. Virol., November 15, 2007; 81(22): 12675 - 12679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sokolova, A. Algeciras-Schimnich, M. Song, S. Sitailo, F. Policht, B. R. Kipp, J. S. Voss, K. C. Halling, A. Ruth, W. King, et al. Chromosomal Biomarkers for Detection of Human Papillomavirus Associated Genomic Instability in Epithelial Cells of Cervical Cytology Specimens J. Mol. Diagn., November 1, 2007; 9(5): 604 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stevens, S. M. Garland, E. Rudland, J. Tan, M. A. Quinn, and S. N. Tabrizi Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results J. Clin. Microbiol., July 1, 2007; 45(7): 2130 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Castle, J. Dockter, C. Giachetti, F. A.R. Garcia, M. K. McCormick, A. L. Mitchell, E. B. Holladay, and D. P. Kolk A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6/E7 Messenger RNA Assay for Detection of Cervical Precancer and Cancer Clin. Cancer Res., May 1, 2007; 13(9): 2599 - 2605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N Kalof and K. Cooper Our approach to squamous intraepithelial lesions of the uterine cervix J. Clin. Pathol., May 1, 2007; 60(5): 449 - 455. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, M. Sadorra, F. A.R. Garcia, A. P. Cullen, A. T. Lorincz, A. L. Mitchell, D. Whitby, R. Chuke, and J. R. Kornegay Mouthwash as a Low-Cost and Safe Specimen Transport Medium for Human Papillomavirus DNA Testing of Cervicovaginal Specimens Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 840 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schatzkin Can Biomarkers Help Us Understand the Nutritional and Lifestyle Factors Important in Cancer Prognosis? J. Nutr., January 1, 2007; 137(1): 249S - 252S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Sandri, P. Lentati, E. Benini, P. Dell'Orto, L. Zorzino, F. M. Carozzi, P. Maisonneuve, R. Passerini, M. Salvatici, C. Casadio, et al. Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples. J. Clin. Microbiol., June 1, 2006; 44(6): 2141 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, A. Aftab, G. Saint-Jean, and L. Mendez Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device. J. Clin. Microbiol., June 1, 2006; 44(6): 2158 - 2159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-L. Huang, A. Chao, S. Hsueh, F.-Y. Chao, C.-C. Huang, J.-E. Yang, C.-Y. Lin, C.-C. Yan, H.-H. Chou, K.-G. Huang, et al. Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-Based Assay for Detection of Human Papillomavirus DNA in Cervical Swab Samples. J. Clin. Microbiol., May 1, 2006; 44(5): 1733 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Y. Hernandez, K. McDuffie, M. T. Goodman, L. R. Wilkens, P. Thompson, X. Zhu, W. Wong, and L. Ning Comparison of Physician- and Self-Collected Genital Specimens for Detection of Human Papillomavirus in Men J. Clin. Microbiol., February 1, 2006; 44(2): 513 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Olaharski, R. Sotelo, G. Solorza-Luna, M. E. Gonsebatt, P. Guzman, A. Mohar, and D. A. Eastmond Tetraploidy and chromosomal instability are early events during cervical carcinogenesis Carcinogenesis, February 1, 2006; 27(2): 337 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Korodi, J. Dillner, E. Jellum, S. Lumme, G. Hallmans, S. Thoresen, T. Hakulinen, P. Stattin, T. Luostarinen, M. Lehtinen, et al. Human Papillomavirus 16, 18, and 33 Infections and Risk of Prostate Cancer: A Nordic Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2952 - 2955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Khan, P. E. Castle, A. T. Lorincz, S. Wacholder, M. Sherman, D. R. Scott, B. B. Rush, A. G. Glass, and M. Schiffman The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice J Natl Cancer Inst, July 20, 2005; 97(14): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Soderlund-Strand, P. Rymark, P. Andersson, J. Dillner, and L. Dillner Comparison between the Hybrid Capture II Test and a PCR-Based Human Papillomavirus Detection Method for Diagnosis and Posttreatment Follow-Up of Cervical Intraepithelial Neoplasia J. Clin. Microbiol., July 1, 2005; 43(7): 3260 - 3266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. P. C. van Ham, J. M. J. E. Bakkers, G. K. Harbers, W. G. V. Quint, L. F. A. G. Massuger, and W. J. G. Melchers Comparison of Two Commercial Assays for Detection of Human Papillomavirus (HPV) in Cervical Scrape Specimens: Validation of the Roche AMPLICOR HPV Test as a Means To Screen for HPV Genotypes Associated with a Higher Risk of Cervical Disorders J. Clin. Microbiol., June 1, 2005; 43(6): 2662 - 2667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, M. Schiffman, D. R. Scott, M. E. Sherman, A. G. Glass, B. B. Rush, J. E. Schussler, S. Wacholder, and A. T. Lorincz Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1311 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, M. Sapp, N. D. Christensen, and J. Dillner Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology J. Gen. Virol., January 1, 2005; 86(1): 65 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Carrilho, L Cirnes, M Alberto, L Buane, N Mendes, and L David Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women J. Clin. Pathol., January 1, 2005; 58(1): 61 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Piyathilake, O. L. Henao, M. Macaluso, P. E. Cornwell, S. Meleth, D. C. Heimburger, and E. E. Partridge Folate Is Associated with the Natural History of High-Risk Human Papillomaviruses Cancer Res., December 1, 2004; 64(23): 8788 - 8793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bernatsky, R. Ramsey-Goldman, C. Gordon, L. Joseph, J.-F. Boivin, R. Rajan, A. Allen, A. D. Moore, M.-H. Leung, and A. Clarke Factors associated with abnormal Pap results in systemic lupus erythematosus Rheumatology, November 1, 2004; 43(11): 1386 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kobayashi, R. M. Greenblatt, K. Anastos, H. Minkoff, L. S. Massad, M. Young, A. M. Levine, T. M. Darragh, V. Weinberg, and K. K. Smith-McCune Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection Cancer Res., September 15, 2004; 64(18): 6766 - 6774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Tsao, E. S. Kim, and W. K. Hong Chemoprevention of Cancer CA Cancer J Clin, May 1, 2004; 54(3): 150 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Goldie, M. Kohli, D. Grima, M. C. Weinstein, T. C. Wright, F. X. Bosch, and E. Franco Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine J Natl Cancer Inst, April 21, 2004; 96(8): 604 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, A. T. Lorincz, D. R. Scott, M. E. Sherman, A. G. Glass, B. B. Rush, S. Wacholder, R. D. Burk, M. M. Manos, J. E. Schussler, et al. Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer J. Clin. Microbiol., September 1, 2003; 41(9): 4022 - 4030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Sahebali, C E Depuydt, K Segers, A J Vereecken, E Van Marck, and J J Bogers Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool? J. Clin. Pathol., September 1, 2003; 56(9): 681 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M R Pillai, P Chacko, L A Kesari, P G Jayaprakash, H N Jayaram, and A C Antony Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer J. Clin. Pathol., August 1, 2003; 56(8): 569 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Moberg, I. Gustavsson, and U. Gyllensten Real-Time PCR-Based System for Simultaneous Quantification of Human Papillomavirus Types Associated with High Risk of Cervical Cancer J. Clin. Microbiol., July 1, 2003; 41(7): 3221 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Coker, S. Bond, M. M. Madeleine, K. Luchok, and L. Pirisi Psychosocial Stress and Cervical Neoplasia Risk Psychosom Med, July 1, 2003; 65(4): 644 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Dahlstrom, K. Adler-Storthz, C. J. Etzel, Z. Liu, L. Dillon, A. K. El-Naggar, M. R. Spitz, J. T. Schiller, Q. Wei, and E. M. Sturgis Human Papillomavirus Type 16 Infection and Squamous Cell Carcinoma of the Head and Neck in Never-Smokers: A Matched Pair Analysis Clin. Cancer Res., July 1, 2003; 9(7): 2620 - 2626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Piras, P S Moore, J Ugalde, M T Perra, A Scarpa, and P Sirigu Detection of human papillomavirus DNA in pterygia from different geographical regions Br. J. Ophthalmol., July 1, 2003; 87(7): 864 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Castellsague and N. Munoz Chapter 3: Cofactors in Human Papillomavirus Carcinogenesis--Role of Parity, Oral Contraceptives, and Tobacco Smoking J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 20 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wacholder Chapter 18: Statistical Issues in the Design and Analysis of Studies of Human Papillomavirus and Cervical Neoplasia J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 125 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Schiffman and P. Castle Epidemiologic Studies of a Necessary Causal Risk Factor: Human Papillomavirus Infection and Cervical Neoplasia J Natl Cancer Inst, March 19, 2003; 95(6): E2 - E2. [Full Text]
|
|
|
|
 |
|
 N. Munoz, F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J.F. Snijders, C. J.L.M. Meijer, and the International Agency for Research on Cancer Mu Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer N. Engl. J. Med., February 6, 2003; 348(6): 518 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Sherman, A. T. Lorincz, D. R. Scott, S. Wacholder, P. E. Castle, A. G. Glass, I. Mielzynska-Lohnas, B. B. Rush, and M. Schiffman Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis J Natl Cancer Inst, January 1, 2003; 95(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Opalka, C. E. Lachman, S. A. MacMullen, K. U. Jansen, J. F. Smith, N. Chirmule, and M. T. Esser Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay Clin. Vaccine Immunol., January 1, 2003; 10(1): 108 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Alazawi, M. Pett, B. Arch, L. Scott, T. Freeman, M. A. Stanley, and N. Coleman Changes in Cervical Keratinocyte Gene Expression Associated with Integration of Human Papillomavirus 16 Cancer Res., December 1, 2002; 62(23): 6959 - 6965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Elfgren, M. Jacobs, J. M. M. Walboomers, C. J. L. M. Meijer, and J. Dillner Rate of Human Papillomavirus Clearance After Treatment of Cervical Intraepithelial Neoplasia Obstet. Gynecol., November 1, 2002; 100(5): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Eiben, M. P. Velders, H. Schreiber, M. C. Cassetti, J. K. Pullen, L. R. Smith, and W. M. Kast Establishment of an HLA-A*0201 Human Papillomavirus Type 16 Tumor Model to Determine the Efficacy of Vaccination Strategies in HLA-A*0201 Transgenic Mice Cancer Res., October 15, 2002; 62(20): 5792 - 5799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Mandelblatt, W. F. Lawrence, L. Gaffikin, K. K. Limpahayom, P. Lumbiganon, S. Warakamin, J. King, B. Yi, P. Ringers, and P. D. Blumenthal Costs and Benefits of Different Strategies to Screen for Cervical Cancer in Less-Developed Countries J Natl Cancer Inst, October 2, 2002; 94(19): 1469 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, S. Wacholder, A. T. Lorincz, D. R. Scott, M. E. Sherman, A. G. Glass, B. B. Rush, J. E. Schussler, and M. Schiffman A Prospective Study of High-Grade Cervical Neoplasia Risk Among Human Papillomavirus-Infected Women J Natl Cancer Inst, September 18, 2002; 94(18): 1406 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Giuliano, M. Papenfuss, M. Abrahamsen, and P. Inserra Differences in Factors Associated with Oncogenic and Nononcogenic Human Papillomavirus Infection at the United States-Mexico Border Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 930 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Levi, B. Kleter, W. G. V. Quint, M. C. S. Fink, C. L. M. Canto, R. Matsubara, I. Linhares, A. Segurado, B. Vanderborght, J. E. Neto, et al. High Prevalence of Human Papillomavirus (HPV) Infections and High Frequency of Multiple HPV Genotypes in Human Immunodeficiency Virus-Infected Women in Brazil J. Clin. Microbiol., September 1, 2002; 40(9): 3341 - 3345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Leachman, M. Shylankevich, M. D. Slade, D. Levine, R. K. Sundaram, W. Xiao, M. Bryan, D. Zelterman, R. E. Tiegelaar, and J. L. Brandsma Ubiquitin-Fused and/or Multiple Early Genes from Cottontail Rabbit Papillomavirus as DNA Vaccines J. Virol., June 27, 2002; 76(15): 7616 - 7624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Mandelblatt, W. F. Lawrence, S. M. Womack, D. Jacobson, B. Yi, Y.-t. Hwang, K. Gold, J. Barter, and K. Shah Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer JAMA, May 8, 2002; 287(18): 2372 - 2381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F X Bosch, A Lorincz, N Munoz, C J L M Meijer, and K V Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol., April 1, 2002; 55(4): 244 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-J. van Doorn, W. Quint, B. Kleter, A. Molijn, B. Colau, M.-T. Martin, Kravang-In, N. Torrez-Martinez, C. L. Peyton, and C. M. Wheeler Genotyping of Human Papillomavirus in Liquid Cytology Cervical Specimens by the PGMY Line Blot Assay and the SPF10 Line Probe Assay J. Clin. Microbiol., March 1, 2002; 40(3): 979 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, A. T. Lorincz, I. Mielzynska-Lohnas, D. R. Scott, A. G. Glass, M. E. Sherman, J. E. Schussler, and M. Schiffman Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are Reproducible J. Clin. Microbiol., March 1, 2002; 40(3): 1088 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kobayashi, T. Darragh, B. Herndier, K. Anastos, H. Minkoff, M. Cohen, M. Young, A. Levine, L. Ahdieh Grant, W. Hyun, et al. Lymphoid Follicles Are Generated in High-Grade Cervical Dysplasia and Have Differing Characteristics Depending on HIV Status Am. J. Pathol., January 1, 2002; 160(1): 151 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. West, D. Flanery, K. Woytek, D. Rangasamy, and V. G. Wilson Functional Mapping of the DNA Binding Domain of Bovine Papillomavirus E1 Protein J. Virol., December 15, 2001; 75(24): 11948 - 11960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lin, L. A. Koutsky, C. W. Critchlow, R. J. Apple, S. E. Hawes, J. P. Hughes, P. Toure, A. Dembele, and N. B. Kiviat HLA Class II DR-DQ and Increased Risk of Cervical Cancer among Senegalese Women Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1037 - 1045. [Abstract] [Full Text] [PDF]
|
|